Skip to main content
. 2012 Aug 21;16(4):R161. doi: 10.1186/cc11484

Table 1.

Description of the study population by period and ICU, Edouard Herriot Hospital, Lyon (France), 2004-2010.

Characteristics Intervention group:
Interrupted surveillance, unit A
Control group:
Continuous surveillance, unit B

Period 1 2004 to 2006 (n = 448) Period 2 2007 to 2010 (n = 492) P Period 1 2004 to 2006 (n = 743) Period 2 2007 to 2010 (n = 881) P
Categorical variable,
n (%)
 Gender, male 308 (68.8) 320 (65.0) 0.23 439 (59.1) 531 (60.3) 0.63
 Patient origin 0.004 <0.001
 Home 70 (15.6) 114 (23.2) 421 (56.7) 421 (47.8)
 Other unit/hospital 378 (84.4) 378 (76.8) 322 (43.3) 460 (52.2)
 Immunosuppresseda 153 (34) 263 (53) <0.001 98 (13.2) 175 (19.9) <0.001
 Diagnosis categorya <0.001 0.060
 Medical 265 (59.2) 161 (32.7) 660 (88.8) 807 (91.6)
 Surgery 183 (40.9) 331 (67.3) 83 (11.2) 74 (8.4)
 Antibioticsa 284 (63.4) 230 (46.8) <0.001 397 (53.4) 629 (71.4) <0.001
 Deceased in-hospital 60 (13.5) 91 (18.8) 0.028 236 (31.9) 256 (29.1) 0.22
Continuous variable,
mean (SD)
 Age, yearsa 56.3 (14.9) 58.5 (15.5) 0.022 61.1 (16.4) 60.7 (59.6) 0.61
 SAPSIIa 51.7 (17.9) 45.4 (21.0) <0.001 55.6 (19.8) 55.5 (18.8) 0.95
 Length of hospital stay, days 12.2 (18.6) 15.3 (25.7) 0.038 14.8 (20.3) 12.0 (17.0) 0.0023
 Length of invasive mechanical ventilation, days 7.7 (14.5) 11.3 (24.7) 0.007 11.1 (19.0) 8.5 (14.5) 0.0015
Incidence of VAP
 Number of VAP 35 84 68 99
 Attack rateb 7.8 17.1 <0.001 9.2 11.2 0.17
 Incidencec (95% CI) 13.4
(9.5-18.4)
22.9
(18.4-28.2)
11.2
(8.7-14.1)
17.1
(14.0-20.8)

NOTE: CI, confidence interval; SD, standard deviation; SAPSII, simplified acute physiological score II; VAP, ventilator-associated pneumonia. a At ICU admission. b Number of VAP per 100 intubated patients. c Number of VAP per 1,000 intubation-days.